Anthocyanin Dose-escalation Study in Healthy Young Adults

March 21, 2019 updated by: Shaoguan University

Anthocyanin Dose-escalation Study in Healthy Young Adults: A CONSORT-compliant, Randomized, Controlled Trial

Anthocyanins are naturally existing, polyphenolic compounds found in the vacuolar sap of the epidermal tissues of flowers and fruits, with a pink, red, blue, or purple color. Recently, study of anthocyanin pigments has drawn more and more interest since several epidemiological studies have demonstrated their health-promoting properties, such as reducing lipid accumulation and decreasing oxidative stress and inflammation. Nevertheless, there is a clear need for advancing understanding with regard to effective amounts of intake for these phytochemicals. The aim of this study was to investigate the efficacy and pharmacokinetics of anthocyanin in healthy volunteers.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shaoguan, Guangdong, China, 512005
        • Shaoguan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Blood test, liver function test, renal function test are normal;
  • Blood lipids, cardiac function are normal;
  • 18.5<BMI<23.9;
  • Regular dietary, seldomly eating outside;
  • Stable condition of body weight in recent 3 months

Exclusion Criteria:

  • > 140 grams of alcohol/week for male and >70 grams of alcohol/week for female, smoking regularly;
  • Known diagnosis of acute diseases or chronic diseases in recent 1 month;
  • Be planning to be pregnant in a year, or being pregnant and lactation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Intake of placebo capsules
Placebo capsules
Active Comparator: 20 mg
Daily intake of 20 mg anthocyanin
Capsules with different anthocyanin content
Active Comparator: 40 mg
Daily intake of 40 mg anthocyanin
Capsules with different anthocyanin content
Active Comparator: 80 mg
Daily intake of 80 mg anthocyanin
Capsules with different anthocyanin content
Active Comparator: 160 mg
Daily intake of 160 mg anthocyanin
Capsules with different anthocyanin content
Active Comparator: 320 mg
Daily intake of 320 mg anthocyanin
Capsules with different anthocyanin content

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma total antioxidant capacity
Time Frame: 2 weeks
Oxidative stress
2 weeks
Plasma malondialdehyde concentrations
Time Frame: 2 weeks
Oxidative stress
2 weeks
Plasma 8-iso-prostaglandin concentrations
Time Frame: 2 weeks
Oxidative stress
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma tumor necrosis factor alpha concentrations
Time Frame: 2 weeks
Inflammatory response
2 weeks
Plasma interleukin-6 concentrations
Time Frame: 2 weeks
Inflammatory response
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2016

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

April 13, 2016

First Submitted That Met QC Criteria

May 2, 2016

First Posted (Estimate)

May 3, 2016

Study Record Updates

Last Update Posted (Actual)

March 25, 2019

Last Update Submitted That Met QC Criteria

March 21, 2019

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • SGU-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Placebo

3
Subscribe